55 results
424B8
NMRD
Nemaura Medical Inc.
11 Sep 23
Prospectus unintentially filed late
4:41pm
. This regulation places significant responsibility on the sponsor of the clinical study including, but not limited to, choosing qualified investigators
PRE 14A
NMRD
Nemaura Medical Inc.
10 Aug 23
Preliminary proxy
4:05pm
with management and one another directly. Under these circumstances, the directors believe designating a lead director to take on responsibility for functions … responsibility in their respective areas of expertise.
The Audit Committee assists the Board with the oversight of our financial reporting, independent
POS AM
oj64p4a 3eh60
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
q6uym5nzgc0a1cuj3
15 May 23
Prospectus supplement with pricing info
4:31pm
CORRESP
sm701
11 May 23
Correspondence with SEC
12:00am
424B5
qw2p wd7d
1 Apr 22
Prospectus supplement for primary offering
4:29pm
CORRESP
b8q zww0p
24 Mar 22
Correspondence with SEC
12:00am
424B5
fd6axe as7
23 Jul 21
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
5m6q3u fv
23 Jul 21
Entry into a Material Definitive Agreement
4:22pm